Search

Susan C Garthwaite

from Chicago, IL
Age ~45

Susan Garthwaite Phones & Addresses

  • Chicago, IL
  • Washington, DC
  • 2539 Bedford St, Stamford, CT 06905 (203) 324-0894 (203) 357-1963
  • Ann Arbor, MI
  • 2539 Bedford St APT 37F, Stamford, CT 06905 (203) 357-1963

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Graduate or professional degree

Resumes

Resumes

Susan Garthwaite Photo 1

Susan Garthwaite

View page
Location:
Washington, DC
Industry:
Primary/Secondary Education
Work:
Fairfax County Public Schools Jan 2006 - Aug 2012
Elementary Mathematics Resource Teacher

Fairfax County Public Schools Sep 2004 - Jan 2006
Title I Mathematics Teacher

Fairfax County Public Schools Sep 2002 - Jun 2004
Sixth Grade General Education Teacher

Fairfax County Public Schools Sep 1999 - Jun 2001
Third Grade General Education Teacher
Education:
University of Virginia 2006 - 2008
Master of Education, Masters, Leadership, Mathematics
George Mason University 2003 - 2005
Master of Education, Masters, Leadership, Education
University of Wisconsin - Madison 1995 - 1999
Bachelors, Bachelor of Science, Elementary Education
Wauwatosa East High School
Skills:
Elementary Education
Lesson Planning
Differentiated Instruction
Curriculum Design
Curriculum Development
Susan Garthwaite Photo 2

Susan Garthwaite

View page

Publications

Us Patents

Aldosterone Antagonist Compositions For Release During Aldosterone Acrophase

View page
US Patent:
20050192259, Sep 1, 2005
Filed:
May 4, 2005
Appl. No.:
11/121638
Inventors:
Susan Garthwaite - Evanston IL, US
Leo Mathur - Vernon Hills IL, US
International Classification:
A61K031/56
US Classification:
514169000
Abstract:
A pharmaceutical composition is provided for administration to a subject mammal such as a human exhibiting a diurnal cycle of plasma aldosterone concentration, the composition comprising a delayed-release formulation of an aldosterone antagonist drug, e.g., eplerenone, in a therapeutically effective amount. The delayed-release formulation, when administered about 6 hours to about 12 hours prior to the acrophase, results in a profile of plasma drug concentration that corresponds substantially to the diurnal cycle of plasma aldosterone concentration.

Aldosterone Antagonist Composition For Release During Aldosterone Acrophase

View page
US Patent:
20020132001, Sep 19, 2002
Filed:
May 11, 2001
Appl. No.:
09/854264
Inventors:
Susan Garthwaite - Evanston IL, US
Leo Mathur - Vernon Hills IL, US
International Classification:
A61K009/22
US Classification:
424/468000
Abstract:
A pharmaceutical composition is provided for administration to a subject mammal such as a human exhibiting a diurnal cycle of plasma aldosterone concentration, the composition comprising a delayed-release formulation of an aldosterone antagonist drug, e.g., eplerenone, in a therapeutically effective amount. The delayed-release formulation, when administered about 6 hours to about 12 hours prior to the acrophase, results in a profile of plasma drug concentration that corresponds substantially to the diurnal cycle of plasma aldosterone concentration.
Susan C Garthwaite from Chicago, IL, age ~45 Get Report